Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 17.92%9.58B | 92.04%2.59B | 32.44%1.5B | -30.60%2.06B | 28.26%3.42B | -9.65%8.12B | -18.15%1.35B | -62.65%1.14B | 24.69%2.97B | 38.92%2.67B |
Cost of revenue | 32.41%7.09B | 81.82%1.8B | 29.33%1.05B | -24.92%1.46B | 72.99%2.78B | -18.38%5.36B | -16.39%987.48M | -65.71%813.1M | 9.94%1.95B | 29.81%1.61B |
Gross profit | -10.14%2.48B | 119.99%793.89M | 40.29%451.73M | -41.42%598.35M | -39.63%640.07M | 13.95%2.76B | -22.61%360.88M | -51.80%321.99M | 67.50%1.02B | 55.48%1.06B |
Operating expense | 18.61%1.67B | 22.44%446.07M | 16.00%393.77M | 19.66%429.22M | 16.03%399.82M | 17.56%1.41B | 18.36%364.31M | 13.04%339.46M | 21.52%358.7M | 17.35%344.6M |
Operating profit | -39.95%815.16M | 10,223.02%347.83M | 431.87%57.96M | -74.48%169.13M | -66.43%240.24M | 10.44%1.36B | -102.17%-3.44M | -104.75%-17.46M | 110.64%662.73M | 84.31%715.58M |
Net non-operating interest income (expenses) | 21.48%-69.62M | 15.93%-18.81M | 28.04%-17.38M | 31.22%-17.16M | 5.32%-16.27M | 9.89%-88.66M | 63.27%-22.37M | -154.99%-24.16M | 4.63%-24.95M | -818.16%-17.19M |
Non-operating interest income | 24.31%45.04M | 29.89%11.53M | 41.75%10.5M | 50.67%9.52M | -1.03%13.49M | 42.16%36.23M | 128.59%8.88M | -64.01%7.41M | 14.80%6.32M | -55.22%13.63M |
Non-operating interest expense | -8.19%114.66M | -2.91%30.33M | -11.67%27.88M | -14.67%26.68M | -3.42%29.77M | 0.82%124.9M | 4.67%31.24M | 5.03%31.56M | -1.25%31.27M | -4.63%30.82M |
Net investment income | 183.58%186.68M | 913.30%112.46M | 25.05%-88.83M | -29.29%49.42M | 9.93%113.64M | -18.57%65.83M | -78.80%11.1M | -748.61%-118.53M | 683.42%69.89M | 7,821.07%103.37M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 261.38%168.03M | 443.57%106.33M | 1,555.87%48.1M | 1,078.23%13.42M | 100.25%176K | -27.52%-104.12M | -2,814.82%-30.95M | -220.50%-3.3M | 102.42%1.14M | -84.39%-71M |
Less:Other special charges | -2,559.15%-166.97M | -7,408.97%-106.33M | -1,169.20%-47.27M | ---- | ---- | -395.20%-6.28M | -195.61%-1.42M | ---3.72M | ---- | ---- |
Less:Write off | -100.96%-1.06M | -100.02%-5K | -111.91%-837K | ---44K | -100.25%-176K | 38.82%110.4M | 1,334.83%32.37M | 356.31%7.03M | --0 | 82.94%71M |
Other non-operating income (expenses) | -1,592.08%-34.27M | -126.29%-26.39M | -211.45%-2.82M | -227.62%-12.35M | 316.56%7.29M | 107.51%2.3M | 4.03%-11.66M | 1,210.53%2.53M | 145.40%9.68M | -43.53%1.75M |
Income before tax | -13.53%1.07B | 1,009.66%521.42M | 98.15%-2.98M | -71.82%202.46M | -52.89%345.08M | 12.14%1.23B | -141.25%-57.32M | -142.45%-160.92M | 213.69%718.49M | 107.93%732.51M |
Income tax | -25.45%326.25M | 17,418.24%157.6M | 37.94%-26.01M | -78.49%49.26M | -42.17%145.41M | 11.52%437.61M | -101.46%-910K | -134.32%-41.92M | 140.46%229.02M | 122.89%251.42M |
Net income | -6.97%739.72M | 744.96%363.82M | 119.36%23.03M | -68.70%153.2M | -58.50%199.67M | 12.48%795.15M | -173.54%-56.41M | -146.32%-119.01M | 265.82%489.48M | 100.88%481.09M |
Net income continuous operations | -6.97%739.72M | 744.96%363.82M | 119.35%23.03M | -68.70%153.2M | -58.50%199.67M | 12.48%795.15M | -173.54%-56.41M | -146.32%-119.01M | 265.82%489.48M | 100.88%481.09M |
Noncontrolling interests | 283.02%30.96M | 102.46%288K | 73.55%-810K | 187.74%2.61M | 3,450.55%28.87M | -132.00%-16.91M | -431.10%-11.69M | -105.94%-3.06M | -154.58%-2.98M | 174.93%813K |
Net income attributable to the company | -12.72%708.76M | 912.87%363.53M | 120.57%23.84M | -69.42%150.59M | -64.44%170.8M | 24.16%812.06M | -161.11%-44.72M | -156.47%-115.94M | 264.86%492.45M | 99.64%480.27M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -12.72%708.76M | 912.87%363.53M | 120.57%23.84M | -69.42%150.59M | -64.44%170.8M | 24.16%812.06M | -161.11%-44.72M | -156.47%-115.94M | 264.86%492.45M | 99.64%480.27M |
Gross dividend payment | ||||||||||
Basic earnings per share | -27.33%88.85 | 775.97%45.29 | 114.04%2.45 | -75.29%18.32 | -68.47%22.79 | 24.11%122.27 | -160.91%-6.7 | -156.47%-17.45 | 263.61%74.14 | 99.50%72.28 |
Diluted earnings per share | -27.33%88.85 | 763.03%44.6746 | 114.04%2.45 | -75.28%18.32 | -68.47%22.79 | 24.17%122.27 | -161.25%-6.7379 | -156.51%-17.45 | 263.46%74.1104 | 99.78%72.28 |
Dividend per share | 0.00%8 | 0.00%8 | 0 | 0 | 0 | 0.00%8 | 0.00%8 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |